- In January 2025, Thermo Fisher Scientific announced the acquisition of Solventum's purification and filtration business for approximately USD 4.1 billion. This strategic move aims to enhance Thermo Fisher's presence in the bioprocessing filtration sector, complementing its existing bioprocessing segment and expanding its tools and services for drug development in the biopharmaceutical industry
- In October 2023, Cytiva, a subsidiary of Danaher Corporation, opened a 33,000-square-foot manufacturing facility in Pune, India. This facility focuses on producing bioprocessing equipment, including tangential flow, virus filtration, and inactivation systems, to cater to the growing demand in the region
- In September 2023, MilliporeSigma introduced the Millex GV Syringe Filters, designed to deliver high throughput and minimize protein binding, making them ideal for various laboratory filtration applications
- In August 2023, GE Healthcare launched the Xcellerex XDR Single-Use Filters, specifically designed to offer high efficiency and minimal extractables, catering to the demanding requirements of biopharmaceutical manufacturing applications
- In July 2023, 3M introduced the Emphaze Filter Capsules, tailored for biopharmaceutical manufacturing. These capsules are engineered to ensure high purity and minimal extractables, meeting the stringent standards of the industry
